Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

FOXC2 and FLT4 Gene Variants in Lymphatic Filariasis.

Identifieur interne : 000E21 ( PubMed/Corpus ); précédent : 000E20; suivant : 000E22

FOXC2 and FLT4 Gene Variants in Lymphatic Filariasis.

Auteurs : Yasmeen Sheik ; Sameera Fatima Qureshi ; Basheeruddin Mohhammed ; Pratibha Nallari

Source :

RBID : pubmed:26091406

English descriptors

Abstract

Lymphatic filariasis is the leading cause of secondary lymphedema wherein lymph transport is impaired due to lymphatic damage. FLT4 signaling and transcription factors such as FOXC2 play an important role in this type of lymphangiogenesis process induced by filarial parasites. The present study aims to assess the association of FLT4 and FOXC2 genes in lymphatic development/remodeling in lymphatic filariasis. A total of 118 lymphatic filariasis patients and 100 non-endemic and 50 endemic healthy subjects were enrolled for the present study. Allele-specific PCR and PCR-RFLP were adopted for the genotyping, and screening of FLT4 and FOXC2 genes was carried out by PCR-SSCP, followed by in-silico and statistical analysis. A novel variation (G357A SNP) was identified on FOXC2 gene screening that may have an effect on codon usage frequency during translational process. In FLT4, A3123G mutation was found in 3.39% of the case subjects but the functional role of this mutation, along with subject's clinical presentations and patient's age, emphasize its pathogenic role in lymphedema development. Two of the subjects exhibit compound heterozygosity (A3123G FLT4 mutation and G357A SNP of FOXC2 gene). As these two genes share a common pathway, we hypothesise a synergistic interaction of these two SNPs in inhibiting the downstream signaling resulting in lymphedema progression.

DOI: 10.1089/lrb.2014.0025
PubMed: 26091406

Links to Exploration step

pubmed:26091406

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">FOXC2 and FLT4 Gene Variants in Lymphatic Filariasis.</title>
<author>
<name sortKey="Sheik, Yasmeen" sort="Sheik, Yasmeen" uniqKey="Sheik Y" first="Yasmeen" last="Sheik">Yasmeen Sheik</name>
<affiliation>
<nlm:affiliation>1 Department of Genetics, Osmania University , Hyderabad, Telangana, India .</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Qureshi, Sameera Fatima" sort="Qureshi, Sameera Fatima" uniqKey="Qureshi S" first="Sameera Fatima" last="Qureshi">Sameera Fatima Qureshi</name>
<affiliation>
<nlm:affiliation>1 Department of Genetics, Osmania University , Hyderabad, Telangana, India .</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mohhammed, Basheeruddin" sort="Mohhammed, Basheeruddin" uniqKey="Mohhammed B" first="Basheeruddin" last="Mohhammed">Basheeruddin Mohhammed</name>
<affiliation>
<nlm:affiliation>2 NFCP (National Filariasis Control program Centre) , Siddipet, Medak, Telangana, India .</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Nallari, Pratibha" sort="Nallari, Pratibha" uniqKey="Nallari P" first="Pratibha" last="Nallari">Pratibha Nallari</name>
<affiliation>
<nlm:affiliation>1 Department of Genetics, Osmania University , Hyderabad, Telangana, India .</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:26091406</idno>
<idno type="pmid">26091406</idno>
<idno type="doi">10.1089/lrb.2014.0025</idno>
<idno type="wicri:Area/PubMed/Corpus">000E21</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000E21</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">FOXC2 and FLT4 Gene Variants in Lymphatic Filariasis.</title>
<author>
<name sortKey="Sheik, Yasmeen" sort="Sheik, Yasmeen" uniqKey="Sheik Y" first="Yasmeen" last="Sheik">Yasmeen Sheik</name>
<affiliation>
<nlm:affiliation>1 Department of Genetics, Osmania University , Hyderabad, Telangana, India .</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Qureshi, Sameera Fatima" sort="Qureshi, Sameera Fatima" uniqKey="Qureshi S" first="Sameera Fatima" last="Qureshi">Sameera Fatima Qureshi</name>
<affiliation>
<nlm:affiliation>1 Department of Genetics, Osmania University , Hyderabad, Telangana, India .</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mohhammed, Basheeruddin" sort="Mohhammed, Basheeruddin" uniqKey="Mohhammed B" first="Basheeruddin" last="Mohhammed">Basheeruddin Mohhammed</name>
<affiliation>
<nlm:affiliation>2 NFCP (National Filariasis Control program Centre) , Siddipet, Medak, Telangana, India .</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Nallari, Pratibha" sort="Nallari, Pratibha" uniqKey="Nallari P" first="Pratibha" last="Nallari">Pratibha Nallari</name>
<affiliation>
<nlm:affiliation>1 Department of Genetics, Osmania University , Hyderabad, Telangana, India .</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Lymphatic research and biology</title>
<idno type="eISSN">1557-8585</idno>
<imprint>
<date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Alleles</term>
<term>Cohort Studies</term>
<term>Elephantiasis, Filarial (diagnosis)</term>
<term>Elephantiasis, Filarial (genetics)</term>
<term>Female</term>
<term>Forkhead Transcription Factors (genetics)</term>
<term>Gene Frequency</term>
<term>Genetic Predisposition to Disease</term>
<term>Genetic Variation</term>
<term>Genotype</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Odds Ratio</term>
<term>Polymorphism, Single Nucleotide</term>
<term>Vascular Endothelial Growth Factor Receptor-3 (genetics)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Forkhead Transcription Factors</term>
<term>Vascular Endothelial Growth Factor Receptor-3</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Alleles</term>
<term>Cohort Studies</term>
<term>Female</term>
<term>Gene Frequency</term>
<term>Genetic Predisposition to Disease</term>
<term>Genetic Variation</term>
<term>Genotype</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Odds Ratio</term>
<term>Polymorphism, Single Nucleotide</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Lymphatic filariasis is the leading cause of secondary lymphedema wherein lymph transport is impaired due to lymphatic damage. FLT4 signaling and transcription factors such as FOXC2 play an important role in this type of lymphangiogenesis process induced by filarial parasites. The present study aims to assess the association of FLT4 and FOXC2 genes in lymphatic development/remodeling in lymphatic filariasis. A total of 118 lymphatic filariasis patients and 100 non-endemic and 50 endemic healthy subjects were enrolled for the present study. Allele-specific PCR and PCR-RFLP were adopted for the genotyping, and screening of FLT4 and FOXC2 genes was carried out by PCR-SSCP, followed by in-silico and statistical analysis. A novel variation (G357A SNP) was identified on FOXC2 gene screening that may have an effect on codon usage frequency during translational process. In FLT4, A3123G mutation was found in 3.39% of the case subjects but the functional role of this mutation, along with subject's clinical presentations and patient's age, emphasize its pathogenic role in lymphedema development. Two of the subjects exhibit compound heterozygosity (A3123G FLT4 mutation and G357A SNP of FOXC2 gene). As these two genes share a common pathway, we hypothesise a synergistic interaction of these two SNPs in inhibiting the downstream signaling resulting in lymphedema progression.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">26091406</PMID>
<DateCreated>
<Year>2015</Year>
<Month>06</Month>
<Day>20</Day>
</DateCreated>
<DateCompleted>
<Year>2016</Year>
<Month>03</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>06</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1557-8585</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>13</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2015</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Lymphatic research and biology</Title>
<ISOAbbreviation>Lymphat Res Biol</ISOAbbreviation>
</Journal>
<ArticleTitle>FOXC2 and FLT4 Gene Variants in Lymphatic Filariasis.</ArticleTitle>
<Pagination>
<MedlinePgn>112-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1089/lrb.2014.0025</ELocationID>
<Abstract>
<AbstractText>Lymphatic filariasis is the leading cause of secondary lymphedema wherein lymph transport is impaired due to lymphatic damage. FLT4 signaling and transcription factors such as FOXC2 play an important role in this type of lymphangiogenesis process induced by filarial parasites. The present study aims to assess the association of FLT4 and FOXC2 genes in lymphatic development/remodeling in lymphatic filariasis. A total of 118 lymphatic filariasis patients and 100 non-endemic and 50 endemic healthy subjects were enrolled for the present study. Allele-specific PCR and PCR-RFLP were adopted for the genotyping, and screening of FLT4 and FOXC2 genes was carried out by PCR-SSCP, followed by in-silico and statistical analysis. A novel variation (G357A SNP) was identified on FOXC2 gene screening that may have an effect on codon usage frequency during translational process. In FLT4, A3123G mutation was found in 3.39% of the case subjects but the functional role of this mutation, along with subject's clinical presentations and patient's age, emphasize its pathogenic role in lymphedema development. Two of the subjects exhibit compound heterozygosity (A3123G FLT4 mutation and G357A SNP of FOXC2 gene). As these two genes share a common pathway, we hypothesise a synergistic interaction of these two SNPs in inhibiting the downstream signaling resulting in lymphedema progression.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sheik</LastName>
<ForeName>Yasmeen</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Genetics, Osmania University , Hyderabad, Telangana, India .</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Qureshi</LastName>
<ForeName>Sameera Fatima</ForeName>
<Initials>SF</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Genetics, Osmania University , Hyderabad, Telangana, India .</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mohhammed</LastName>
<ForeName>Basheeruddin</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>2 NFCP (National Filariasis Control program Centre) , Siddipet, Medak, Telangana, India .</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nallari</LastName>
<ForeName>Pratibha</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>1 Department of Genetics, Osmania University , Hyderabad, Telangana, India .</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>06</Month>
<Day>02</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Lymphat Res Biol</MedlineTA>
<NlmUniqueID>101163587</NlmUniqueID>
<ISSNLinking>1539-6851</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D051858">Forkhead Transcription Factors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C082078">mesenchyme fork head 1 protein</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.10.1</RegistryNumber>
<NameOfSubstance UI="D040321">Vascular Endothelial Growth Factor Receptor-3</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051858" MajorTopicYN="N">Forkhead Transcription Factors</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005787" MajorTopicYN="N">Gene Frequency</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014644" MajorTopicYN="Y">Genetic Variation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D040321" MajorTopicYN="N">Vascular Endothelial Growth Factor Receptor-3</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2015</Year>
<Month>6</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2015</Year>
<Month>6</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2016</Year>
<Month>3</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">26091406</ArticleId>
<ArticleId IdType="doi">10.1089/lrb.2014.0025</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E21 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000E21 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:26091406
   |texte=   FOXC2 and FLT4 Gene Variants in Lymphatic Filariasis.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:26091406" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024